Gefitinib inhibits retina angiogenesis by affecting VEGF signaling pathway

In conclusion, these findings indicate that Gefitinib is critical for the treatment of retina angiogenesis, which is associated with VEGF/Cyclin E/CDK2/CD31 pathway.

Source: Biomedicine and Pharmacotherapy - March 22, 2018 Category: Drugs & Pharmacology Source Type: research